Cargando…

MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi

Fungi are a rich source of secondary metabolites which constitutes a valuable and diverse chemical space of natural products. Medicinal fungi have been used in traditional medicine to treat human ailments for centuries. To date, there is no devoted resource on secondary metabolites and therapeutic u...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivek-Ananth, R. P., Sahoo, Ajaya Kumar, Kumaravel, Kavyaa, Mohanraj, Karthikeyan, Samal, Areejit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693784/
https://www.ncbi.nlm.nih.gov/pubmed/35424258
http://dx.doi.org/10.1039/d0ra10322e
_version_ 1784619213532430336
author Vivek-Ananth, R. P.
Sahoo, Ajaya Kumar
Kumaravel, Kavyaa
Mohanraj, Karthikeyan
Samal, Areejit
author_facet Vivek-Ananth, R. P.
Sahoo, Ajaya Kumar
Kumaravel, Kavyaa
Mohanraj, Karthikeyan
Samal, Areejit
author_sort Vivek-Ananth, R. P.
collection PubMed
description Fungi are a rich source of secondary metabolites which constitutes a valuable and diverse chemical space of natural products. Medicinal fungi have been used in traditional medicine to treat human ailments for centuries. To date, there is no devoted resource on secondary metabolites and therapeutic uses of medicinal fungi. Such a dedicated resource compiling dispersed information on medicinal fungi across published literature will facilitate ongoing efforts towards natural product based drug discovery. Here, we present the first comprehensive manually curated database on Medicinal Fungi Secondary metabolites And Therapeutics (MeFSAT) that compiles information on 184 medicinal fungi, 1830 secondary metabolites and 149 therapeutics uses. Importantly, MeFSAT contains a non-redundant in silico natural product library of 1830 secondary metabolites along with information on their chemical structures, computed physicochemical properties, drug-likeness properties, predicted ADMET properties, molecular descriptors and predicted human target proteins. By comparing the physicochemical properties of secondary metabolites in MeFSAT with other small molecules collections, we find that fungal secondary metabolites have high stereochemical complexity and shape complexity similar to other natural product libraries. Based on multiple scoring schemes, we have filtered a subset of 228 drug-like secondary metabolites in MeFSAT database. By constructing and analyzing chemical similarity networks, we show that the chemical space of secondary metabolites in MeFSAT is highly diverse. The compiled information in MeFSAT database is openly accessible at: https://cb.imsc.res.in/mefsat/.
format Online
Article
Text
id pubmed-8693784
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-86937842022-04-13 MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi Vivek-Ananth, R. P. Sahoo, Ajaya Kumar Kumaravel, Kavyaa Mohanraj, Karthikeyan Samal, Areejit RSC Adv Chemistry Fungi are a rich source of secondary metabolites which constitutes a valuable and diverse chemical space of natural products. Medicinal fungi have been used in traditional medicine to treat human ailments for centuries. To date, there is no devoted resource on secondary metabolites and therapeutic uses of medicinal fungi. Such a dedicated resource compiling dispersed information on medicinal fungi across published literature will facilitate ongoing efforts towards natural product based drug discovery. Here, we present the first comprehensive manually curated database on Medicinal Fungi Secondary metabolites And Therapeutics (MeFSAT) that compiles information on 184 medicinal fungi, 1830 secondary metabolites and 149 therapeutics uses. Importantly, MeFSAT contains a non-redundant in silico natural product library of 1830 secondary metabolites along with information on their chemical structures, computed physicochemical properties, drug-likeness properties, predicted ADMET properties, molecular descriptors and predicted human target proteins. By comparing the physicochemical properties of secondary metabolites in MeFSAT with other small molecules collections, we find that fungal secondary metabolites have high stereochemical complexity and shape complexity similar to other natural product libraries. Based on multiple scoring schemes, we have filtered a subset of 228 drug-like secondary metabolites in MeFSAT database. By constructing and analyzing chemical similarity networks, we show that the chemical space of secondary metabolites in MeFSAT is highly diverse. The compiled information in MeFSAT database is openly accessible at: https://cb.imsc.res.in/mefsat/. The Royal Society of Chemistry 2021-01-12 /pmc/articles/PMC8693784/ /pubmed/35424258 http://dx.doi.org/10.1039/d0ra10322e Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Vivek-Ananth, R. P.
Sahoo, Ajaya Kumar
Kumaravel, Kavyaa
Mohanraj, Karthikeyan
Samal, Areejit
MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi
title MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi
title_full MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi
title_fullStr MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi
title_full_unstemmed MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi
title_short MeFSAT: a curated natural product database specific to secondary metabolites of medicinal fungi
title_sort mefsat: a curated natural product database specific to secondary metabolites of medicinal fungi
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693784/
https://www.ncbi.nlm.nih.gov/pubmed/35424258
http://dx.doi.org/10.1039/d0ra10322e
work_keys_str_mv AT vivekananthrp mefsatacuratednaturalproductdatabasespecifictosecondarymetabolitesofmedicinalfungi
AT sahooajayakumar mefsatacuratednaturalproductdatabasespecifictosecondarymetabolitesofmedicinalfungi
AT kumaravelkavyaa mefsatacuratednaturalproductdatabasespecifictosecondarymetabolitesofmedicinalfungi
AT mohanrajkarthikeyan mefsatacuratednaturalproductdatabasespecifictosecondarymetabolitesofmedicinalfungi
AT samalareejit mefsatacuratednaturalproductdatabasespecifictosecondarymetabolitesofmedicinalfungi